Adjustments, Extensions, Disclaimers, and Continuations: When Do Patent Term Adjustments Make Sense?

This document cites

• US Code - 35 U.S.C. § 101 Inventions Patentable
• US Code - 35 U.S.C. § 121 Divisional Applications
• US Code - 35 U.S.C. § 154 Contents and Term of Patent; Provisional Rights
• US Code - 35 U.S.C. § 156 Extension of Patent Term
• US Code - 35 U.S.C. § 253 Disclaimer



See all quotations

• Code of Federal Regulations - Reduction of period of adjustment of patent term
• Code of Federal Regulations - Patent term adjustment determination
• Code of Federal Regulations - Calculation of patent term extension for a human drug, antibiotic drug or human biological product
• Federal Cases - Cardiac Pacemakers, Inc. v. St. Jude Medical, Inc.
• Federal Cases - Longi, In re
• Federal Cases - Merck & Co., Inc. v. Kessler
• Federal Cases - In re Van Ornum
• Federal Cases - Merck & Co., Inc. v. Hi-Tech Pharmacal Co., Inc.
• Federal Cases - Application of Schneller
• Federal Cases - Roche Products, Inc. v. Bolar Pharmaceutical Co., Inc.
• Federal Cases - Agilent Technologies, Inc. v. Affymetrix, Inc.
• Federal Cases - Otsuka Pharm. Co. v. Sandoz, Inc.
• Federal Cases - Reynolds Metals Co. v. Continental Group, Inc.
• Federal Cases - Bayer Ag v. Carlsbad Technology, Inc.
• Federal Cases - In re Fallaux
• Federal Cases - Wyeth v. Kappos
• Federal Cases - Tafas v. Dudas
• Federal Cases - Skoczen v. Shinseki
• Federal Cases - Tafas v. Kappos
• Federal Cases - King Pharmaceuticals v. Teva Pharmaceuticals Usa, Civil Action No. 05-3855 (JAP).
• US Code - 35 U.S.C. § 155, 155A Repealed